Earnings Novo Nordisk’s Confidence Gap: When Raised Guidance Isn’t Enough
There is a peculiar arithmetic at work in Copenhagen these days: a company raises its full-year outlook, beats on revenue, and still watches its shares slide. Novo Nordisk delivered exactly...